Outcomes of Allogeneic HSCT in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Resource Constrained Settings.

Key Points

• Outcomes from allogeneic HSC transplant show promising survival rates in patients with paroxysmal nocturnal hemoglobinuria.
• Survival rates exceeded 60% within the first year of transplantation, indicating favorable responses to the procedure.
• Evaluations based on clinical data from resource-constrained settings provide insights into treatment efficacy.
• Highlighting the need for improved access to allogeneic HSCT options in low-resource environments.